253 related articles for article (PubMed ID: 7621240)
1. Antisense oligonucleotide technology in the development of cancer therapeutics.
Tseng BY; Brown KD
Cancer Gene Ther; 1994 Mar; 1(1):65-71. PubMed ID: 7621240
[No Abstract] [Full Text] [Related]
2. Applications of antisense oligonucleotides in oncology.
Pierga JY; Magdelenat H
Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):237-61. PubMed ID: 7920172
[TBL] [Abstract][Full Text] [Related]
3. Application of antisense oligonucleotides for gene functionalization and target validation.
Bennett CF; Cowsert LM
Curr Opin Mol Ther; 1999 Jun; 1(3):359-71. PubMed ID: 11713801
[TBL] [Abstract][Full Text] [Related]
4. Antisense approaches to cancer gene therapy.
Mercola D; Cohen JS
Cancer Gene Ther; 1995 Mar; 2(1):47-59. PubMed ID: 7621254
[TBL] [Abstract][Full Text] [Related]
5. Locked nucleic acids: a promising molecular family for gene-function analysis and antisense drug development.
Orum H; Wengel J
Curr Opin Mol Ther; 2001 Jun; 3(3):239-43. PubMed ID: 11497347
[TBL] [Abstract][Full Text] [Related]
6. Preclinical and clinical experience of antisense therapy for solid tumors.
Webb MS; Zon G
Curr Opin Mol Ther; 1999 Aug; 1(4):458-63. PubMed ID: 11713760
[TBL] [Abstract][Full Text] [Related]
7. The therapeutic potential of antisense oligonucleotides.
Sharma HW; Narayanan R
Bioessays; 1995 Dec; 17(12):1055-63. PubMed ID: 8634067
[TBL] [Abstract][Full Text] [Related]
8. A potential role for antisense oligonucleotide analogues in the development of oncogene targeted cancer chemotherapy.
Tidd DM
Anticancer Res; 1990; 10(5A):1169-82. PubMed ID: 2241097
[TBL] [Abstract][Full Text] [Related]
9. Anti-oncogene and tumor suppressor gene therapy--examples from a lung cancer animal model.
Zhang WW; Roth JA
In Vivo; 1994; 8(5):755-69. PubMed ID: 7727723
[TBL] [Abstract][Full Text] [Related]
10. Modulation of gene expression by antisense and antigene oligodeoxynucleotides and small interfering RNA.
Mahato RI; Cheng K; Guntaka RV
Expert Opin Drug Deliv; 2005 Jan; 2(1):3-28. PubMed ID: 16296732
[TBL] [Abstract][Full Text] [Related]
11. Locked nucleic acid: a potent nucleic acid analog in therapeutics and biotechnology.
Jepsen JS; Sørensen MD; Wengel J
Oligonucleotides; 2004; 14(2):130-46. PubMed ID: 15294076
[TBL] [Abstract][Full Text] [Related]
12. Nucleic-acid therapeutics: basic principles and recent applications.
Opalinska JB; Gewirtz AM
Nat Rev Drug Discov; 2002 Jul; 1(7):503-14. PubMed ID: 12120257
[TBL] [Abstract][Full Text] [Related]
13. A hitchhiker's guide to antisense and nonantisense biochemical pathways.
Branch AD
Hepatology; 1996 Dec; 24(6):1517-29. PubMed ID: 8938189
[TBL] [Abstract][Full Text] [Related]
14. Hybridization of antisense reagents to RNA.
Sohail M; Southern EM
Curr Opin Mol Ther; 2000 Jun; 2(3):264-71. PubMed ID: 11249620
[TBL] [Abstract][Full Text] [Related]
15. Antisense imaging: and miles to go before we sleep?
Lewis MR; Jia F
J Cell Biochem; 2003 Oct; 90(3):464-72. PubMed ID: 14523980
[TBL] [Abstract][Full Text] [Related]
16. Antisense strategies for oncogene inactivation.
Stein CA; Benimetskaya L; Mani S
Semin Oncol; 2005 Dec; 32(6):563-72. PubMed ID: 16338422
[TBL] [Abstract][Full Text] [Related]
17. [Antisense oligonucleotides: a new therapeutic approach].
Guinot P; Temsamani J
Pathol Biol (Paris); 1998 May; 46(5):347-54. PubMed ID: 9769897
[TBL] [Abstract][Full Text] [Related]
18. Antisense therapy for cancer.
Gleave ME; Monia BP
Nat Rev Cancer; 2005 Jun; 5(6):468-79. PubMed ID: 15905854
[TBL] [Abstract][Full Text] [Related]
19. Antisense oligonucleotide technology: from EST to therapeutics.
Giles RV
Curr Opin Mol Ther; 2000 Jun; 2(3):238-52. PubMed ID: 11249617
[TBL] [Abstract][Full Text] [Related]
20. [Effects of STAT3 antisense oligonucleotide on proliferation and apoptosis of non-small cell lung cancer cell line A549].
Zhu BR; Cai JM; Tang GS; Li BL; Gao F; Cui JG; Liu HC
Ai Zheng; 2007 Aug; 26(8):820-7. PubMed ID: 17697540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
